# AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver

> **NCT01361061** · — · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 450 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01361061
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2018-10-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01361061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01361061, "AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01361061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*